Insider and congress filings
West Pharmaceutical Services, Inc. (WST)
About West Pharmaceutical Services, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Michel Lagarde
- Employees
- 10,800
- Listed since
- -
- Market value
- $23.7B
- Price to earnings
- 42.8
- Earnings per share
- $7.98
- Dividend yield
- 0.26%
Earnings
6 reported quarters · next on Oct 22, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 23, 2026 | $2.37 | $2.08 | $872.3M | $840.0M | EPS beatRevenue beat |
| Q1 FY2026reported Apr 23, 2026 | $2.13 | $1.68 | $844.9M | $780.3M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $2.04 | $1.83 | $805.0M | $794.9M | EPS beatRevenue in line |
| Q3 FY2025reported Oct 23, 2025 | $1.96 | $1.68 | $804.3M | $785.7M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 24, 2025 | $1.84 | $1.51 | $766.2M | $726.1M | EPS beatRevenue beat |
| Q1 FY2025reported Apr 24, 2025 | $1.45 | $1.22 | $698.0M | $713.0M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 12, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Robert W. McMahonSVP, Chief Financial Officer | $292K | $5.8M | $5.7M | $11.8M |
| Eric M. GreenPresident and CEO, Chair of Board | $1.2M | $3.3M | $2.7M | $7.2M |
| Shane A. CampbellSVP, Chief Proprietary Segment Officer | $369K | $1.2M | $841K | $2.4M |
| Annette F. FavoriteSVP, Chief Human Resources Officer | $450K | $343K | $597K | $1.4M |
The summary compensation table from the 2025 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $2.4B | 6,651,784 | -2.7% | 9.40% |
| Vanguard Capital Management LLC | $1.7B | 4,613,134 | -1.5% | 6.52% |
| Vanguard Portfolio Management LLC | $1.4B | 4,015,766 | -1.9% | 5.67% |
| FMR LLC | $1.3B | 3,574,816 | +186.0% | 5.05% |
| State Street Corp | $1.2B | 3,348,698 | +1.7% | 4.73% |
| Artisan Partners Limited Partnership | $865.8M | 2,411,792 | -9.3% | 3.41% |
| Bank Of New York Mellon Corp | $733.7M | 2,043,823 | -17.1% | 2.89% |
| Generation Investment Management LLP | $728.2M | 2,028,322 | -9.6% | 2.86% |
| Geode Capital Management, LLC | $680.6M | 1,903,279 | -0.5% | 2.69% |
| T. Rowe Price Investment Management, Inc. | $648.0M | 1,805,019 | -22.9% | 2.55% |
| Morgan Stanley | $568.1M | 1,582,546 | +8.5% | 2.24% |
| Jpmorgan Chase & Co | $413.0M | 1,164,527 | +11.6% | 1.64% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
2 filings of 331 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Chad WintersVP, Chief Accounting Officer | Sold | 896 | $300.67 | $269K | Apr 27, 2026 | 2d |
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold | 2,817 | $305.20 | $860K | Apr 27, 2026 | 2d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in WST
20 disclosures of 39 on record · median 30d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +7.9%S&P +0.4% · vs S&P 500 +7.6% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +7.8%S&P +1.6% · vs S&P 500 +6.2% | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +45.8%S&P +13.0% · vs S&P 500 +32.8% | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +44.8%S&P +9.8% · vs S&P 500 +35.0% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +54.6%S&P +21.5% · vs S&P 500 +33.2% | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +55.2%S&P +27.8% · vs S&P 500 +27.5% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +55.1%S&P +28.2% · vs S&P 500 +26.9% | May 19, 2025 | Jun 10, 2025 | 22d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +54.8%S&P +43.1% · vs S&P 500 +11.7% | Apr 23, 2025 | May 12, 2025 | 19d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +77.0%S&P +53.5% · vs S&P 500 +23.5% | Apr 8, 2025 | May 8, 2025 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +50.3%S&P +36.4% · vs S&P 500 +13.9% | Mar 12, 2025 | Apr 10, 2025 | 29d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | +53.1%S&P +28.3% · vs S&P 500 +24.8% | Feb 25, 2025 | Mar 27, 2025 | 30d |
| Jared MoskowitzDependent child | Stock | Sale | $1,001 - $15,000 | +70.0%S&P +25.2% · vs S&P 500 +44.8% | Feb 13, 2025 | Mar 6, 2025 | 21d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +66.4%S&P +24.3% · vs S&P 500 +42.1% | Feb 19, 2025 | Mar 6, 2025 | 15d |
| Jared Moskowitz | Stock | Sale | $1,001 - $15,000 | +4.5%S&P +27.7% · vs S&P 500 -23.2% | Nov 8, 2024 | Dec 9, 2024 | 31d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +14.1%S&P +30.5% · vs S&P 500 -16.4% | Oct 14, 2024 | Nov 8, 2024 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +15.3%S&P +32.9% · vs S&P 500 -17.6% | Oct 11, 2024 | Nov 8, 2024 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +12.5%S&P +43.7% · vs S&P 500 -31.2% | Aug 2, 2024 | Sep 6, 2024 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.0%S&P +48.2% · vs S&P 500 -36.2% | Aug 5, 2024 | Sep 6, 2024 | 32d |
| Jared MoskowitzDependent childFiled late | Stock | Purchase | $1,001 - $15,000 | -4.6%S&P +60.3% · vs S&P 500 -64.9% | Dec 28, 2023 | Aug 21, 2024 | 237d |
| Jared MoskowitzFiled late | Stock | Purchase | $1,001 - $15,000 | -12.1%S&P +70.1% · vs S&P 500 -82.2% | Jul 14, 2023 | Aug 21, 2024 | 404d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Robert W. McMahonSVP & Chief Financial Officer | Option exercise | 7,149 | Aug 11, 2026 |
| Robert W. McMahonSVP & Chief Financial Officer | Tax withholding | 3,109 | Aug 11, 2026 |
| Janet Brutschea HaugenDirector | Stock award | 46 | Jun 30, 2026 |
| Shane Alden CampbellSVP, Proprietary Segment | Option exercise | 770 | May 12, 2026 |
| Shane Alden CampbellSVP, Proprietary Segment | Tax withholding | 219 | May 12, 2026 |
| Douglas A. MichelsDirector | Stock award | 791 | May 4, 2026 |
| William F. FeeheryDirector | Stock award | 791 | May 4, 2026 |
| Goldman Myla LaiDirector | Stock award | 791 | May 4, 2026 |
| Deborah L. KellerDirector | Stock award | 791 | May 4, 2026 |
| Robert F. FrielDirector | Stock award | 791 | May 4, 2026 |
| Mark A. ButhmanDirector | Stock award | 791 | May 4, 2026 |
| Paolo PucciDirector | Stock award | 791 | May 4, 2026 |
| Janet Brutschea HaugenDirector | Stock award | 791 | May 4, 2026 |
| Stephen H. LockhartDirector | Stock award | 791 | May 4, 2026 |
| Molly JosephDirector | Stock award | 791 | May 4, 2026 |
| Chad WintersVP, Chief Accounting Officer | Option exercise | 896 | Apr 27, 2026 |
| Annette F. FavoriteSr. VP & Chief HR Officer | Option exercise | 2,817 | Apr 27, 2026 |
| Janet Brutschea HaugenDirector | Stock award | 52 | Mar 31, 2026 |
| Rodolphe Jean PoussotSVP, Strategy & Corporate Dev | Stock award | 1,477 | Mar 1, 2026 |
| Norman D. Finch Jr.SVP, GC & Corporate Secretary | Stock award | 4,342 | Mar 1, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling WST?
Across the 2 most recent open-market filings shown here, 0 were purchases and 2 were sales.
Which members of Congress have traded WST?
Ro Khanna, Lisa C. McClain, Robert Bresnahan, Jared Moskowitz disclosed WST transactions in the filings shown here.
Is WST in the S&P 500 or the Nasdaq 100?
West Pharmaceutical Services, Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are WST trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.